ÂÜÀòÂÒÂ×

MÃ¥rten Winge is a senior life science executive with extensive experience of commercializing innovative new technology internationally. He has occupied senior executive and board positions in numerous private and public companies, managing multiple strategic processes, including financing rounds and exits through trade sales as well as IPO. He is currently CEO of Strike Pharma AB, Stockholm (a DNA analysis technology company based on in situ sequencing) and member, advisory board member and chairman of a number of highly innovative life science companies. MÃ¥rten has a BSc in chemistry from the University of Stockholm and an MSc in molecular biology from Karolinska Institute, Sweden.